UHPLC-MS/MS method for pharmacokinetic and bioavailability determination of five bioactive components in raw and various processed products of Polygala tenuifolia in rat plasma.

CONCLUSIONS: The pharmacokinetic and bioavailability parameters of each compound can facilitate future clinical studies. PMID: 32956609 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32956609?dopt=Abstract

Source: Pharmaceutical Biology - September 23, 2020 Category: Drugs & Pharmacology Tags: Pharm Biol Source Type: research